Logo for OssDsign

OssDsign Investor Relations Material

Latest events

Logo for OssDsign

Q2 2024

OssDsign
Logo for OssDsign

Q2 2024

20 Aug, 2024
Logo for OssDsign

Q1 2024

14 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from OssDsign

Access all reports
Segment Data
Access more data
Revenue by
Geography
U.S.
Germany
Rest of Europe
U.K.
Other
Expenses by
Financials
OssDsign AB designs, manufactures, and sells implants and material technology for bone regeneration. The company's products are used to treat bone defects in the hard palate and other areas as well as to support dental implants. The company has strategic relations with several companies across Europe and the US, and markets their products to customers all over the world. OssDsign's aim is to be an innovative and leading specialty pharma player within the fast growing bone reconstruction market by providing products that offer unique opportunities for superior clinical outcomes, thereby adding value for patients, healthcare providers and investors.